Business Viability Is Healthcare Access: Why VBCA Exists

Value-based care programs were designed to improve quality and reduce cost. In practice, their complexity has become a quiet threat to the practices communities depend on. This is the argument behind everything VBCA builds.

The Quiet Transfer

Medicare now adjusts up to 9% of a practice's Part B revenue based on quality scores, episode costs, and peer benchmarks—and mandatory models will push the stakes to 12%. The scoring is knowable, but it is not intuitive, and it resets every year. A perfect 100% performance rate on a topped-out measure earns 7 of the 10 available points. Half of all clinicians fall below the national median cost score, most without visibility into why. A measure mix that scored well last year can quietly lose points this year under new benchmarks.

The result is a transfer that nobody voted for: practices that understand their data capture the upside, and practices that don't fund it.

The Burden Falls Where the Staffing Isn't

A large health system has a department for this. A four-physician cardiology practice has Thursday evenings. The numbers show what that difference produces: in 2024, 27% of small practices were penalized under MIPS, and 49% of solo clinicians received the maximum 9% penalty. These are not, by and large, practices delivering poor care. They are practices without the staff to decode a rulebook that runs thousands of pages and changes annually.

The consequences aren't abstract. A practice that misreads the program doesn't just lose revenue—it can close. And when it closes, patients lose the clinician who served their community for decades, replaced by a long drive to the nearest alternative. The practices most exposed to program complexity are often essential access points in their regions. That is what makes this an access problem, not a compliance problem.

What We Believe

Four convictions follow from that diagnosis. They shape what we build, what we recommend, and what we tell CMS.

• Policy expertise matters. Understanding what CMS is trying to accomplish—not just what it requires—changes how you approach compliance. The practices that read the intent behind a rule see the next rule coming.
• Cost is a clinical problem. The patients appearing in high-cost episodes are signaling unmanaged chronic disease. Administrative controls don't change that; informed clinical decisions do. Addressing cost means addressing care.
• Registries are decision systems. A registry that only submits data is a receipt printer. Your MIPS data should be the compass for your business decisions—which measures to select, where your costs diverge from peers, what next year's rules make more or less valuable.
• Compliance shouldn't be a cost center. Quality reporting should be a revenue driver, not overhead. Most practices leave value on the table—not because the value isn't there, but because nobody showed them where it is.

What That Means in Practice

It means the analytics have to do the heavy lifting a department would do—scoring your position exactly as CMS will, projecting the payment impact before CMS finalizes it, and drilling to the individual patient when a gap needs closing. It means the people interpreting that data have to have read the rule that created it. And it means showing up when the rules are still being written: we submit formal comments on proposed rules, push back when policies create unintended burdens, and publish what we're watching each rulemaking cycle.

None of that is compliance for its own sake. It is business viability as a prerequisite for access. Practices that succeed under these programs stay open, independent, and able to keep serving their communities—which is the outcome the programs were supposed to produce in the first place.